Alere Inc. (ALR) - Medical Equipment - Deals and Alliances Profile

Date: October 18, 2016
Pages: 98
Price:
US$ 250.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: AF6C82E2120EN
Leaflet:

Download PDF Leaflet

Alere Inc. (ALR) - Medical Equipment - Deals and Alliances Profile
Summary

Alere Inc. (Alere) is one of the leading providers of point-of-care diagnostics solutions and services with focus on cardiology, women’s health, infectious diseases, diabetes, oncology, and toxicology. It offers testing and monitoring products including point-of-care and laboratory tests within the infectious disease, cardiometabolic disease, toxicology and patient self-testing domains. It also offers diabetic testing supplies, including blood glucose monitors, test strips, lancets, lancing devices, and control solutions, and other related medical supplies in the US. Alere offers its products and services to hospitals, reference laboratories, point-of-care settings, self-insured employees, wholesale and retail drug stores, and mass merchandisers. The company operates through subsidiaries and a network of distributors in the Americas, Europe, the Middle East, Asia-Pacific and Africa. Alere is headquartered in Waltham, Massachusetts, the US.

Alere Inc. (ALR) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope
  • Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
  • Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
  • Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
  • Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
  • Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
  • Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
  • Business Description - A brief description of the company's operations.
  • Key Employees - A list of the key executives of the company.
  • Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
  • Key Competitors - A list of the key competitors of the company.
  • Key Recent Developments - A brief on recent news about the company.
Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements - The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy - The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company - Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers. - The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company - Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research - Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company.
Alere Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016
Alere Inc., Medical Equipment Deals By Type, 2010 to YTD 2016
Alere Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016
Alere Inc., Medical Equipment, Deals By Market, 2010 to YTD 2016
Alere Inc., Medical Equipment, Deals Summary, 2010 to YTD 2016
Alere Inc., Medical Equipment, Deal Details
Private Equity
Pharos Capital Group Acquires Majority Stake in TechLab
Exponent Private Equity Acquires BBI Diagnostics from Alere for USD162 Million
Partnerships
Axis-Shield Enters into Licensing Agreement with Hangzhou Joinstar Biomedical
Axis-Shield Diagnostic Enters into Licensing Agreement with Siemens Healthcare Diagnostics
Alere Exercises Option For Licensing Agreement With Miraculins For Endoglin Products
VitaPath Genetics Enters Into Licensing Agreement With Alere
Thermo Fisher Scientific Enters Into Licensing Agreement With Alere
Alere Enters Into Licensing Agreement With Roche Diagnostics
Roche Diagnostics Enters Into Licensing Agreement With Alere
Chembio Terminates Distribution Agreement With Alere
Alere Enters Into Co-Development Agreement With AT&T
EKF Diagnostics Enters Into Distribution Agreement With Alere
Spartan Bioscience Enters Into Distribution Agreement With Alere
Systagenix Wound Management Enters Into Co-Development Agreement With Alere
Laboratorios Rubio Enters Into Distribution Agreement With Alere Healthcare
AnaSpec Enters Into Distribution Agreement With Bioeasy Diagnostica
BG Medicine Enters Into An Agreement With Inverness Medical Innovations
FIND Enters Into Agreement With Standard Diagnostics
Miraculins Enters Into An Agreement With Inverness Medical Innovations
Inverness Medical Innovations Enters Into Distribution Agreement With Epocal
AdnaGen Extends Licensing Agreement With KellBenx
Debt Offering
Alere Raises USD425 Million in Private Placement of 6.37% Notes Due 2023
Alere Completes Private Placement Of Notes Due 2020 For US$425 Million
Alere Completes Private Placement Of Notes Due 2018 For US$450 Million
Alere Completes Private Placement Of Senior Subordinate Notes For US$400 Million
Asset Transactions
QIAGEN Acquires Circulating Tumor Cell Technology from AdnaGen
Coppersmith Capital Management Reportedly Wants Alere To Explore Sale Of Its Drug Testing And Toxicology Businesses For Up To US$5 Billion
Acquisition
Abbott Labs to Acquire Alere
Alere Acquires US Diagnostics USD60 Million
Ron Zwanziger Plans to Acquire Alere for USD3.82 Billion
Alere Completes Acquisition Of Epocal For Up To US$241 Million
Alere Acquires eScreen for USD296 Million
Arriva Medical Acquires AmMed Direct For US$23 Million
Arriva Medical Acquires Direct Diabetic Source
Alere Completes Acquisition Of Medical Automation System
Alere Acquires Arriva Medical From Palm Beach Capital For US$83 Million
Alere Completes Acquisition Of Axis-Shield, Diagnostic Test Maker, For US$389 Million
Alere Acquires Lab Data Systems
Alere Holdings Bermuda Acquires 78% Stake Of AdnaGen From OncoVista Innovative Therapies
EKF Diagnostics Acquires Quotient Diagnostics
Inverness Medical Innovations Acquires 78.13% Stake In Standard Diagnostics
Inverness Medical Innovations To Acquire Kroll Lab Specialists From Kroll
Alere Inc. - Key Competitors
Key Employees
Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Financial Announcements
Sep 06, 2016: Alere Reports Second Quarter 2016 Financial Results
Aug 17, 2016: Alere Reports First Quarter 2016 Financial Results
Aug 08, 2016: Alere Files Form 10-K, Reports Fourth Quarter and Full Year 2015 Financial Results
Nov 04, 2015: Alere Reports Third Quarter 2015 Financial Results
May 05, 2015: Alere Reports Preliminary First Quarter 2015 Financial Results and Announces 2014 Restatement
Feb 10, 2015: Alere Announces Fourth Quarter 2014 Results
Corporate Communications
Jul 23, 2015: Dr. Geoffrey S. Ginsburg Joins Alere Board
Mar 09, 2015: Alere Announces Chief Financial Officer Transition
Legal and Regulatory
Oct 15, 2015: Alere Receives U.S. HHS Approval to Electronically Process Drug Tests for Department of Transportation-Regulated Employees
Product News
Mar 18, 2016: Alere Comments on Alere Anticoagulation Monitoring Technology
Jul 16, 2015: Alere Receives FDA CLIA Waiver for Alere i Strep A Rapid Molecular Test
Apr 02, 2015: Alere Receives FDA Clearance for Alere i Strep A Rapid Molecular Test
Mar 02, 2015: Alere Receives IVD CE Mark for Alere q HIV-1/2 Detect Assay for Molecular Diagnosis of HIV at the Point of Care
Jan 07, 2015: Alere Receives FDA CLIA Waiver for Alere i Influenza A & B Test
Jan 06, 2015: FDA grants first CLIA waiver for nucleic acid-based flu diagnostic test
Product Approvals
Apr 02, 2015: Alere Receives FDA Clearance for Alere i Strep A Rapid Molecular Test
Mar 02, 2015: Alere Receives IVD CE Mark for Alere q HIV-1/2 Detect Assay for Molecular Diagnosis of HIV at the Point of Care
Jan 06, 2015: FDA grants first CLIA waiver for nucleic acid-based flu diagnostic test
Other Significant Developments
Jun 10, 2015: New Approach on HIV Viral Load Testing
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer 98

LIST OF TABLES

Alere Inc., Medical Equipment, Key Facts, 2015
Alere Inc., Medical Equipment, Deals Summary, 2010 to YTD 2016
Alere Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016
Alere Inc., Medical Equipment Deals By Type, 2010 to YTD 2016
Alere Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016
Alere Inc., Deals By Market, 2010 to YTD 2016
Alere Inc., Medical Equipment, Deals Summary, 2010 to YTD 2016
Pharos Capital Group Acquires Majority Stake in TechLab
Exponent Private Equity Acquires BBI Diagnostics from Alere for USD162 Million
Axis-Shield Enters into Licensing Agreement with Hangzhou Joinstar Biomedical
Axis-Shield Diagnostic Enters into Licensing Agreement with Siemens Healthcare Diagnostics
Alere Exercises Option For Licensing Agreement With Miraculins For Endoglin Products
VitaPath Genetics Enters Into Licensing Agreement With Alere
Thermo Fisher Scientific Enters Into Licensing Agreement With Alere
Alere Enters Into Licensing Agreement With Roche Diagnostics
Roche Diagnostics Enters Into Licensing Agreement With Alere
Chembio Terminates Distribution Agreement With Alere
Alere Enters Into Co-Development Agreement With AT&T
EKF Diagnostics Enters Into Distribution Agreement With Alere
Spartan Bioscience Enters Into Distribution Agreement With Alere
Systagenix Wound Management Enters Into Co-Development Agreement With Alere
Laboratorios Rubio Enters Into Distribution Agreement With Alere Healthcare
AnaSpec Enters Into Distribution Agreement With Bioeasy Diagnostica
BG Medicine Enters Into An Agreement With Inverness Medical Innovations
FIND Enters Into Agreement With Standard Diagnostics
Miraculins Enters Into An Agreement With Inverness Medical Innovations
Inverness Medical Innovations Enters Into Distribution Agreement With Epocal
AdnaGen Extends Licensing Agreement With KellBenx
Alere Raises USD425 Million in Private Placement of 6.37% Notes Due 2023
Alere Completes Private Placement Of Notes Due 2020 For US$425 Million
Alere Completes Private Placement Of Notes Due 2018 For US$450 Million
Alere Completes Private Placement Of Senior Subordinate Notes For US$400 Million
QIAGEN Acquires Circulating Tumor Cell Technology from AdnaGen
Coppersmith Capital Management Reportedly Wants Alere To Explore Sale Of Its Drug Testing And Toxicology Businesses For Up To US$5 Billion
Abbott Labs to Acquire Alere
Alere Acquires US Diagnostics USD60 Million
Ron Zwanziger Plans to Acquire Alere for USD3.82 Billion
Alere Completes Acquisition Of Epocal For Up To US$241 Million
Alere Acquires eScreen for USD296 Million
Arriva Medical Acquires AmMed Direct For US$23 Million
Arriva Medical Acquires Direct Diabetic Source
Alere Completes Acquisition Of Medical Automation System
Alere Acquires Arriva Medical From Palm Beach Capital For US$83 Million
Alere Completes Acquisition Of Axis-Shield, Diagnostic Test Maker, For US$389 Million
Alere Acquires Lab Data Systems
Alere Holdings Bermuda Acquires 78% Stake Of AdnaGen From OncoVista Innovative Therapies
EKF Diagnostics Acquires Quotient Diagnostics
Inverness Medical Innovations Acquires 78.13% Stake In Standard Diagnostics
Inverness Medical Innovations To Acquire Kroll Lab Specialists From Kroll
Alere Inc., Key Competitors
Alere Inc., Key Employees
Alere Inc., Subsidiaries 69

LIST OF FIGURES

Alere Inc., Medical Equipment, Deals by Type, 2010 to YTD 2016
Alere Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016
Alere Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016
Alere Inc., Medical Equipment, Deals By Market, 2010 to YTD 2016
Alere Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016
Alere Inc., Medical Equipment, Deals by Type, 2010 to YTD 2016
Alere Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016
Alere Inc., Medical Equipment, Deals by Market, 2010 to YTD 2016
Skip to top


Ask Your Question

Alere Inc. (ALR) - Medical Equipment - Deals and Alliances Profile
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: